138 related articles for article (PubMed ID: 14574015)
21. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
22. Genetic screening of patients with medullary thyroid cancer in a referral center in Greece during the past two decades.
Sarika HL; Papathoma A; Garofalaki M; Saltiki K; Pappa T; Pazaitou-Panayiotou K; Anastasiou E; Alevizaki M
Eur J Endocrinol; 2015 Apr; 172(4):501-9. PubMed ID: 25624014
[TBL] [Abstract][Full Text] [Related]
23. Segregation of the V804L mutation and S836S polymorphism of exon 14 of the RET gene in an extended kindred with familial medullary thyroid cancer.
Patócs A; Valkusz Z; Igaz P; Balogh K; Tóth M; Varga I; Rácz K
Clin Genet; 2003 Mar; 63(3):219-23. PubMed ID: 12694233
[TBL] [Abstract][Full Text] [Related]
24. Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Ponder MA; Ponder BA
Clin Endocrinol (Oxf); 1995 Jul; 43(1):123-7. PubMed ID: 7641404
[TBL] [Abstract][Full Text] [Related]
25. [Germline mutations of the ret proto-oncogene in Chilean patients with hereditary and sporadic medullary thyroid carcinoma].
Wohllk N; Becker P; Youlton R; Cote GJ; Gagel RF
Rev Med Chil; 2001 Jul; 129(7):713-8. PubMed ID: 11552438
[TBL] [Abstract][Full Text] [Related]
26. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
Fink M; Weinhüsel A; Niederle B; Haas OA
Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
[TBL] [Abstract][Full Text] [Related]
27. A rare extracellular D631Y germline mutation of the RET proto-oncogene in two Korean families with multiple endocrine neoplasia 2A.
Bae SJ; Kim DJ; Kim JY; Park SY; Choi SH; Song YD; Ki CS; Chung JH
Thyroid; 2006 Jun; 16(6):609-14. PubMed ID: 16839264
[TBL] [Abstract][Full Text] [Related]
28. Genotypic characteristics and their association with phenotypic characteristics of hereditary medullary thyroid carcinoma in Korea.
Jung KY; Kim SM; Kim MJ; Cho SW; Kim BW; Lee YS; Jeong JJ; Nam KH; Chung WY; Lee KE; Chung EJ; Kim HJ; Park DJ; Sung MW; Park CS; Cho BY; Park YJ; Chang HS
Surgery; 2018 Aug; 164(2):312-318. PubMed ID: 29779869
[TBL] [Abstract][Full Text] [Related]
29. Genetic testing in medullary thyroid carcinoma syndromes: mutation types and clinical significance.
Heshmati HM; Gharib H; Khosla S; Abu-Lebdeh HS; Lindor NM; Thibodeau SN
Mayo Clin Proc; 1997 May; 72(5):430-6. PubMed ID: 9146685
[TBL] [Abstract][Full Text] [Related]
30. Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B.
Skinner MA; DeBenedetti MK; Moley JF; Norton JA; Wells SA
J Pediatr Surg; 1996 Jan; 31(1):177-81; discussion 181-2. PubMed ID: 8632274
[TBL] [Abstract][Full Text] [Related]
31. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
32. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
33. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
34. Hereditary medullary thyroid cancer in Slovenia--genotype-phenotype correlations.
Bergant D; Hocevar M; Besic N; Glavac D; Korosec B; Caserman S
Wien Klin Wochenschr; 2006 Jul; 118(13-14):411-6. PubMed ID: 16865646
[TBL] [Abstract][Full Text] [Related]
35. Medullary carcinoma of the thyroid gland and the MEN 2 syndromes.
Skinner MA; Wells SA
Semin Pediatr Surg; 1997 Aug; 6(3):134-40. PubMed ID: 9263335
[TBL] [Abstract][Full Text] [Related]
36. Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study.
Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C
Thyroid; 2019 Mar; 29(3):368-377. PubMed ID: 30618340
[TBL] [Abstract][Full Text] [Related]
37. [Predictive genetic investigations. Individualization of diagnosis and treatment in families with multiple endocrine neoplasia type II].
Engelbach M; Kunt T; Kann P; Manfras B; Hankeln T; Forst T; Pfützner A; Heerdt S; Walgenbach S; Lehnert H; Beyer J
Dtsch Med Wochenschr; 2000 Jan; 125(3):37-44. PubMed ID: 10681997
[TBL] [Abstract][Full Text] [Related]
38. Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma.
Eng C; Mulligan LM; Smith DP; Healey CS; Frilling A; Raue F; Neumann HP; Pfragner R; Behmel A; Lorenzo MJ
Genes Chromosomes Cancer; 1995 Mar; 12(3):209-12. PubMed ID: 7536460
[TBL] [Abstract][Full Text] [Related]
39. [Prophylactic thyroidectomy in children at risk for medullary thyroid carcinoma].
Torres de Aguirre A; Martínez Carol A; Cabello Laureano R; García Valles C; Gómez Gila A; del Valle Núñez J
Cir Pediatr; 2005 Jul; 18(3):106-8. PubMed ID: 16209369
[TBL] [Abstract][Full Text] [Related]
40. Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?
Romei C; Tacito A; Molinaro E; Agate L; Bottici V; Viola D; Matrone A; Biagini A; Casella F; Ciampi R; Materazzi G; Miccoli P; Torregrossa L; Ugolini C; Basolo F; Vitti P; Elisei R
Clin Endocrinol (Oxf); 2015 Jun; 82(6):892-9. PubMed ID: 25440022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]